The same pathogenic variants (KRAS c.35G>T and TP53 c.743G>A) found in FFPE specimens from Patients 5 and 6 were detected in their ctDNA samples before surgery, but were not present in the plasma after successful tumor removal. Here, KRAS is linked to neoplasm.